𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

✍ Scribed by Whitehead, V M; Shuster, J J; Vuchich, M J; Mahoney, D H; Lauer, S J; Payment, C; Koch, P A; Cooley, L D; Look, A T; Pullen, D J; Camitta, B

Book ID
110056225
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
93 KB
Volume
19
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High-dose methotrexate improves clinical
High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude total therapy study X
✍ Abromowitch, Minnie ;Ochs, Judith ;Pui, Ching-Hon ;Kalwinsky, David ;Rivera, Gas πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 682 KB

High-dose methotrexate (HDMTX, 1,000 mg/m2) and cranial irradiation/sequential chemotherapy (RTSC) were compared for ability to extend complete remission durations in children with acute lymphoblastic leukemia (ALL). Three hundred thirty patients were enrolled in the study, according to our criteria

A pilot study of intermediate-dose metho
A pilot study of intermediate-dose methotrexate and cytosine arabinoside, β€œSpread-out” or β€œUp-front,” in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia a pediatric oncology group study
✍ Robert A. Krance; Edward M. Newman; Donald Pinkel; Yaddanapudi Ravindranath; Mic πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 723 KB

One hundred six children with newly diagnosed non-T-, non-B-cell acute lymphoblastic leukemia (ALL) were treated in a Pediatric Oncology Group (POG) pilot study in which six courses of intermediate-dose methotrexate (MTX) and cytosine arabinoside (Ara-C) (1 g/m2 each) were added to a "backbone" of s